The Need for RSV Prophylaxis in LMICs-Reference-Cited by-同舟云学术

The Need for RSV Prophylaxis in LMICs

Published:2024-09-10 Issue: Volume: Page:
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Pérez Casas Carmen¹,Tagarro Alfredo²,Bassat Quique³⁴⁵,Rojo Pablo⁶

Affiliation:

1. aUnitaid, Grand-Saconnex, Switzerland

2. bInfanta Sofía University Hospital; Universidad Europea, Instituto de Investigación 12 de Octubre, Madrid, Spain

3. cISGlobal, Hospital Clínic, Universitat de Barcelona, Spain, Centro de Investigação em Saúde de Manhiça, Mozambique

4. dICREA, Barcelona, Hospital Sant Joan de Déu, Universitat de Barcelona, Spain

5. eCIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; and

6. fUniversidad Complutense; Instituto de Investigación 12 de Octubre; Hospital 12 de Octubre, Madrid, Spain

Publisher

American Academy of Pediatrics (AAP)

Link

https://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2024-067062/1703611/peds.2024-067062.pdf

Reference7 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

2. Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost-effectiveness in low- and middle-income countries;Fitzpatrick;Vaccine,2023

3. IAVI/Wellcome. Expanding access to monoclonal antibody-based products. A global call to action. August 2020. Available at: https://www.iavi.org/wp-content/uploads/2023/10/Expanding-access-to-monoclonal-antibody-based-products.pdf. Accessed May 10, 2024

4. Nirsevimab for prevention of RSV in term and late-preterm infants;Muller;N Engl J Med,2023

5. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study;Ares-Gómez;Lancet Infect Dis,2024